Mutational analysis of the BPTI folding pathway: II. Effects of aromatic → leucine substitutions on folding kinetics and thermodynamics

Protein Science

Volumn 6, Issue 7, 1997, Pages 1563-1576

  Zhang, Jian Xin ^a,b   Goldenberg, David P ^a  

^a UNIVERSITY OF UTAH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aromatic residues; Bovine pancreatic trypsin inhibitor; Disulfide bonds; Folding kinetics; Hydrophobic residues; Protein folding; Stability

Indexed keywords

APROTININ; AROMATIC AMINO ACID; DISULFIDE; LEUCINE; MUTANT PROTEIN; PHENYLALANINE; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISULFIDE BOND; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STABILITY; THERMODYNAMICS;

BOVINAE;

EID: 0030806962     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560060720     Document Type: Article

References (57)

1. Alber T. 1989. Mutational effects on protein stability. Annu Rev Biochem 58:165-798.
2. Alber T, Sun D-P, Nye JA, Muchmore DC, Matthews BW. 1987. Temperature-sensitive mutations of bacteriophage T4 lysozyme occur at sites with low mobility and low solvent accessibility in the folded protein. Biochemistry 26:3754-3758.
3. Baldwin RL. 1986. Temperature dependence of the hydrophobic interaction in protein folding. Proc Natl Acad Sci USA 85:8069-8072.
4. Barrick D, Baldwin RL. 1993. The molten globule intermediate of apomyoglobin and the process of protein folding. Protein Sci 2:869-876.
5. Beasty AM, Hurle MR, Manz JT, Stackhouse T, Onuffer JJ, Matthews CR. 1986. Effects of the phenylalanine-22 → leucine, glutamic acid-49 → methionine, glycine-234 → aspartic acid, and glycine-234 → lysine mutations on the folding and stability of the alpha subunit of tryptophan synthase from Escherichia coli. Biochemistry 25:2965-2974.
6. Creighton TE. 1974. The single-disulphide intermediates in the refolding of reduced pancreatic trypsin inhibitor. J Mol Biol 57:603-624.
7. Creighton TE. 1977a. Conformational restrictions on the pathway of folding and unfolding of the pancreatic trypsin inhibitor. J Mol Biol 113:275-293.
8. Creighton TE. 1977b. Energetics of folding and unfolding of pancreatic trypsin inhibitor. J Mol Biol 113:295-312.
9. Creighton TE. 1983. An empirical approach to protein conformation, stability and flexibility. Biopolymers 22:49-58.
10. Creighton TE. 1988. On the relevance of non-random polypeptide conformations for protein folding. Biophys Chem 31:155-162.
11. Creighton TE. 1990. Protein folding. Biochem J 270:1-16.
12. Creighton TE, Darby NJ, Kemmink J. 1996. The roles of partly folded intermediates in protein folding. FASEB J 10:110-118.
13. Creighton TE, Goldenberg DP. 1984. Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor. J Mol Biol 179:497-526.
14. Daggett V, Li A, Itzhaki LS, Otzen DE, Fersht AR. 1996. Structure of the transition state for folding of a protein derived from experiment and simulation. J Mol Biol 257:430-440.
15. Darby NJ, Morin PE, Talbo G, Creighton TE. 1995. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates. J Mol Biol 249:463-477.
16. Dill KA. 1990. Dominant forces in protein folding. Biochemistry 29:7133-7155.
17. Dobson CM, Evans PA, Radford SE. 1994. Understanding how proteins fold: The lysozyme story so far. Trends Biochem Sci 19:31-37.
18. Fersht AR. 1995. Mapping the structures of transition states and intermediates in folding: Delineation of pathways at high resolution. Phil Trans Roval Soc Series B 348:11-15.
19. Garvey EP, Swank J, Matthews CR. 1989. A hydrophobic cluster forms early in the folding of dihydrofolate reductase. Proteins 6:259-266.
20. Goldenberg DP. 1985. Dissecting the roles of individual interactions in protein stability: Lessons from a circularized protein. J Cell Biochem 29:321-335.
21. Goldenberg DP. 1988. Kinetic analysis of the folding and unfolding of a mutant form of bovine pancreatic trypsin inhibitor lacking the cysteine-14 and -38 thiols. Biochemistry 27:2481-2489.
22. Goldenberg DP. 1989. Analysis of protein conformation by gel electrophoresis. In: Creighton TE, ed. Protein structure: A practical approach. Oxford: IRL Press. pp 225-250.
23. Goldenberg DP. 1992. Mutational analysis of protein folding and stability. In: Creighton TE, ed. Protein folding. New York: W. H. Freeman, pp 353-403.
24. Goldenberg DP, Berger JM, Laheru DA, Wooden S, Zhang JX. 1992. Genetic dissection of pancreatic trypsin inhibitor. Proc Natl Acad Sci USA 59:5083-5087.
25. Goldenberg DP, Frieden RW, Haack JA, Morrison TB. 1989. Mutational analysis of a protein-folding pathway. Nature 335:127-132.
26. Hughson FM, Barrick D, Baldwin RL. 1991. Probing the stability of a partly folded apomyoglobin intermediate by site-directed mutagenesis. Biochemistry 30:4113-4118.
27. Itzhaki LS, Otzen DE, Fersht AR. 1995. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: Evidence for a nucleation-condensation mechanism for protein folding. J Mol Biol 254:260-288.
28. Kim PS, Baldwin RL. 1990. Intermediates in the folding reactions of small proteins. Annu Rev Biochem 59:631-660.
29. Kraulis PJ. 1991. MOLSCRIPT: A program to produce both detailed and schematic plot of protein structures. J Appl Crystallogr 24:946-950.
30. Makhatadze GI, Privalov PL. 1995. Energetics of protein structure. Adv Protein Chem 47:307-425.
31. Marks CB, Naderi H, Kosen PA, Kuntz ID, Anderson S. 1987. Mutants of bovine pancreatic trypsin inhibitor lacking cysteines 14 and 38 can fold properly. Science 235:1370-1373.
32. Marmorino JL, Pielak GJ. 1995. A native tertiary interaction stabilizes the A state of cytochrome c. Biochemistry 34:3140-3143.
33. Matouschek A, Kellis JJ, Serrano L, Bycroft M, Fersht AR. 1990. Transient folding intermediates characterized by protein engineering. Nature 346:-440-445.
34. Matthews BW. 1993a. Structural and genetic analysis of protein stability. Annu Rev Biochem 62:139-160.
35. Matthews CR. 1993b. Pathways of protein folding. Annu Rev Biochem 62:653-683.
36. Mendoza JA, Jarstfer MB, Goldenberg DP. 1994. Effects of amino acid replacements on the reductive unfolding kinetics of pancreatic trypsin inhibitor. Biochemistry 33:1143-1148.
37. Miranker AD, Dobson CM. 1996. Collapse and cooperativity in protein folding. Curr Opin Struct Biol 6:31-42.
38. 1H NMR assignments and three-dimensional structure of Ala14/Ala38 bovine pancreatic trypsin inhibitor based on two-dimensional NMR and distance geometry. In: Nall BT, Dill KA, eds. Conformations and forces in protein folding. Washington, D.C.: American Association for the Advance-ment of Science, pp 86-114.
39. Oas TG, Kim PS. 1988. A peptide model of a protein folding intermediate. Nature 336:42-48.
40. Peng ZY, Wu LC, Schulman BA, Kim PS. 1995. Does the molten globule have a native-like tertiary fold? Philos Trans K Soc Land B Biol Sci 348:43-41.
41. Perry KM, Onuffer JJ, Gittelman MS, Barmat L, Matthews CR. 1989. Long-range electrostatic interactions can influence the folding, stability, and cooperativity of dihydrofolate reductase. Biochemistry 28:7961-7968.
42. Ptilsyn OB. 1995. Structures of folding intermediates. Curr Opin Struct Biol 5:74-78.
43. Reisfeld RA, Lewis UJ, Williams DE. 1962. Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature 195:281-283.
44. Serrano L, Matouschek A, Fersht AR. 1992. The folding of an enzyme. III. Structure of the transition state for unfolding of barnase analysed by a protein engineering procedure. J Mol Biol 224:805-818.
45. Singh R, Whitesides GM. 1993. Thiol-disulfide interchange. In: Patai S, Rappoport Z, eds. The chemistry of sulphur-containing functional groups. Chichester (England): John Wiley & Sons, pp 633-658.
46. Staley JP. 1993. Structural studies of early intermediates in the folding pathway of bovine pancreatic trypsin inhibitor. [Ph.D thesis]. Cambridge. Massachu-setts: Massachusetts Institute of Technology.
47. Staley JP, Kirn PS. 1994. Formation of a native-like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitor. Protein Sci 3:1822-1832.
48. Tsuji T, Chrunyk BA, Chen X, Matthews CR. 1993. Mutagenic analysis of the interior packing of an alpha/beta barrel protein. Effects on the stabilities and rates of interconversion of the native and partially folded forms of the alpha subunit of tryptophan synthase. Biochemistry 32:5566-5575.
49. 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements. J Mol Biol 229:1125-1146.
50. 1H nuclear magnetic resonance study. J Mol Biol 222:353-371.
51. Wagner G, Bruhwiler D, Wüthrich K. 1987. Reinvestigation of the aromatic side chains in the basic pancreatic trypsin inhibitor by heteronuclear two-dimensional nuclear magnetic resonance. J Mol Biol 796:227-231.
52. Weissman JS, Kim PS. 1991. Reexamination of the folding of BPTI: Predominance of native intermediates. Science 253:1386-1393.
53. Weissman JS, Kim PS. 1992. Kinetic role of nonnative species in the folding of bovine pancreatic trypsin inhibitor. Proc Natl Acad Sci USA 59:9900-9904.
54. Weissman JS, Kim PS. 1995. A kinetic explanation for the rearrangement pathway of BPTI folding. Nature Struct Biol 2:1123-1130.
55. Wlodawer A, Deisenhofer J, Huber R. 1987. Comparison of two highly refined structures of bovine pancreatic trypsin inhibitor. J Mol Biol 193:145-156.
56. Zhang J-X, Goldenberg DP. 1993. Amino acid replacement that eliminates kinetic traps in the folding pathway of pancreatic trypsin inhibitor. Biochemistry 32:14075-14081.
57. Zhang J-X, Goldenberg DP. 1997. Mutational analysis of the BPTI folding pathway: I. Effects of aromatic → leucine substitutions on the distribution of folding intermediates. Protein Sci 6:1549-1562.